Strength
30 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332041310
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA211823On Market Since
6/25/2019
Pharmacological Classes
Neuraminidase Inhibitor
Neuraminidase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
69097090443•Cipla USA Inc.
$0.1519
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
00093818064•Teva Pharmaceuticals USA Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
00527513762•Lannett Company Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
27241013909•Ajanta Pharma USA Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
47781038426•Alvogen Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
59651059760•Aurobindo Pharma Limited
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
64380087975•Strides Pharma Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
68180067801•Lupin Pharmaceuticals Inc.
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
69238127306•Amneal Pharmaceuticals NY LLC
$0.1548
per ML
OSELTAMIVIR 6 MG/ML SUSPENSION
Generic
70710116506•Zydus Pharmaceuticals (USA) Inc.
$0.1548
per ML